ArticleCancers2023

Expression of Soluble Form of Aurora A as a Predictive Factor for Neoadjuvant Therapy in Breast Cancer Patients: A Single-Center Pilot Study.

Pawel Winter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.